1620 Investment Advisors »

X4 Pharmaceuticals shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7k 10k 0.67
2024-06-30 $5.8k 10k 0.58
2024-03-31 $14k 10k 1.39
2023-09-30 $11k 10k 1.09
2023-06-30 $19k 10k 1.94

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
NEA Management Company
BlackRock
BlackRock
Vanguard Group
OrbiMed Advisors
Kingdon Capital Management
Soleus Capital Management
Perceptive Advisors
Geode Capital Management
State Street Corporation
Ensign Peak Advisors
Sio Capital Management
Schonfeld Strategic Advisors
Pale Fire Capital SE

View all funds holding X4 Pharmaceuticals